6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma

      correction

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Correction to: British Journal of Cancer; 10.1038/s41416-019-0506-6; published online 28 June 2019. This article was originally published under a standard license to Publish, but has now been made available under a CC BY license. The PDF and HTML versions of the paper have been modified accordingly.

          Related collections

          Author and article information

          Contributors
          j.evans@beatson.gla.ac.uk
          Journal
          Br J Cancer
          Br. J. Cancer
          British Journal of Cancer
          Nature Publishing Group UK (London )
          0007-0920
          1532-1827
          30 July 2019
          30 July 2019
          1 October 2019
          : 121
          : 7
          : 625
          Affiliations
          [1 ]ISNI 0000 0001 2193 314X, GRID grid.8756.c, University of Glasgow, Beatson West of Scotland Cancer Centre, ; Glasgow, UK
          [2 ]ISNI 0000 0004 1936 9967, GRID grid.258622.9, Department of Gastroenterology and Hepatology, , Kindai University Faculty of Medicine, ; Osaka, Japan
          [3 ]ISNI 0000 0000 9142 8600, GRID grid.413083.d, David Geffen School of Medicine, , UCLA Medical Center, ; Los Angeles, CA USA
          [4 ]ISNI 0000 0004 0470 5454, GRID grid.15444.30, Severance Hospital, , Yonsei University, ; Seoul, South Korea
          [5 ]ISNI 0000 0004 0572 7815, GRID grid.412094.a, National Taiwan University Hospital and National Taiwan University Cancer Center, ; Taipei, Taiwan
          [6 ]ISNI 0000 0001 2168 5385, GRID grid.272242.3, Department of Hepatobiliary and Pancreatic Oncology, , National Cancer Center Hospital East, ; Kashiwa, Japan
          [7 ]GRID grid.428696.7, Former employee of Eisai Ltd, ; Hatfield, UK
          [8 ]ISNI 0000 0004 0599 8842, GRID grid.418767.b, Eisai Inc., ; Woodcliff Lake, NJ USA
          [9 ]Unit of Internal Medicine, University of Bologna, S.Orsola-Malpighi Hospital, Bologna, Italy
          [10 ]GRID grid.416167.3, Tisch Cancer Institute at Mount Sinai, ; New York, NY USA
          Article
          534
          10.1038/s41416-019-0534-2
          6889263
          31363170
          © The Author(s) 2019

          Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

          Categories
          Correction
          Custom metadata
          © Cancer Research UK 2019

          Oncology & Radiotherapy

          cancer

          Comments

          Comment on this article